Bibliografie
1. Siegel, R., Ward, E., Brawley, O., & Jemal, A. (2011). The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Cancer Journal for Clinicians, 61(4), 212-236.
2. Siegel, R. L., Miller, K. D., & Jemal, A. (2015). Cancer statistics, 2015. CA: a cancer journal for clinicians, 65(1), 5-29.
3. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., ... & Muñoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of pathology, 189(1), 12-19.
4. Lag, R., Harkins, D., Krapcho, M., Mariotto, A., Miller, B. A., Feuer, E. J., ... & Hayat, M. (1975). Seer cancer statistics review. Bethesda, National Cancer Institute, 1975-2003.
5. Berrington, D. G. A., & Green, J. (2007). Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. International journal of cancer. Journal international du cancer, 120(4), 885-891.
6. Waggoner, S. E., Darcy, K. M., Tian, C., & Lanciano, R. (2010). Smoking behavior in women with locally advanced cervical carcinoma: a Gynecologic Oncology Group study. American journal of obstetrics and gynecology, 202(3), 283-e1.
7. González, D. C., Franceschi, S., Green, J., La Vecchia, C., Peto, J., Plummer, M., ... & Crossley, B. (2006). Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int. J. Cancer, 119, 1108-1124.
8. DiSaia, P. J., & Creasman, W. T. (2012). Clinical gynecologic oncology.Elsevier Health Sciences.
9. Tinelli, A., Prudenzano, R., Malvasi, A., Santantonio, M., & Lorusso, V. (2010). Emergency endovascular nanopharmacologic treatment in advanced gynecological cancers. International Journal of Gynecological Cancer, 20(7), 1250-1255.
10. Lim, A. K., Agarwal, R., Seckl, M. J., Newlands, E. S., Barrett, N. K., & Mitchell, A. W. (2002). Embolization of Bleeding Residual Uterine Vascular Malformations în Patients with Treated Gestational Trophoblastic Tumors. Radiology, 222(3), 640-644.
11. Tinelli, A., Prudenzano, R., Malvasi, A., Santantonio, M., & Lorusso, V. (2010). Emergency endovascular nanopharmacologic treatment in advanced gynecological cancers. International Journal of Gynecological Cancer, 20(7), 1250-1255.
12. Committee on Gynecologic Practice. (2004). ACOG Committee Opinion.Uterine artery embolization. Obstetrics and gynecology, 103(2), 403.
13. Kirby, J. M., Kachura, J. R., Rajan, D. K., Sniderman, K. W., Simons, M. E., & Windrim, R. C. (2009). Arterial embolization for primary post-partum hemorrhage. Journal of Vascular and Interventional Radiology, 20(8), 1036-1045.
14. Stancato-Pasik, A., Mitty, H. A., Richard 3rd, H. M., & Eshkar, N. (1997). Obstetric embolotherapy: effect on menses and pregnancy. Radiology, 204(3), 791-793.
15. Banaschak, A., Stösslein, F., Kielbach, O., Bilek, K., & Elling, D. (1984). Therapeutic vascular embolization in life-threatening gynecologic hemorrhages. Zentralblatt fur Gynakologie, 107(17), 1050-1056.
16. Hansch, E., Chitkara, U., McAlpine, J., El-Sayed, Y., Dake, M. D., & Razavi, M. K. (1999). Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. American journal of obstetrics and gynecology, 180(6), 1454-1460.
17. Colombo, N., Preti, E., Landoni, F., Carinelli, S., & Colombo, A. (2013). Cancerul endometrial: Ghidul de practică clinică ESMO privind diagnosticul, tratamentul şi urmărirea bolii.